基本信息
浏览量:325
职业迁徙
个人简介
His clinical research investigates methods related to cancer clinical trials, and he chaired trials for men with metastatic prostate cancer that led to licensing of previous (mitoxantrone) and current (docetaxel) standard chemotherapy.
His laboratory research evaluates effects of the tumour microenvironment on outcome of cancer therapy. He is an editor of the Basic Science of Oncology textbook, now in its 5th edition that is used by trainees in all branches of oncology. Dr. Tannock was a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) from 2001-2004. He received the alumnus award from M.D. Anderson Hospital, Houston, USA (1989), the Warwick Prize from the National Cancer Institute of Canada (2003), an honorary degree (DSc) from London University, UK (2009), and the European Society of Medical Oncology (ESMO) award (2012), the first non-European to receive this award. He chairs the scientific audit committee of the European Organisation for Research and Treatment of Cancer (EORTC) and is a member of the EORTC Board.
Dr. Tannock was appointed a Member of the Order of Canada in December 2013.
His laboratory research evaluates effects of the tumour microenvironment on outcome of cancer therapy. He is an editor of the Basic Science of Oncology textbook, now in its 5th edition that is used by trainees in all branches of oncology. Dr. Tannock was a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) from 2001-2004. He received the alumnus award from M.D. Anderson Hospital, Houston, USA (1989), the Warwick Prize from the National Cancer Institute of Canada (2003), an honorary degree (DSc) from London University, UK (2009), and the European Society of Medical Oncology (ESMO) award (2012), the first non-European to receive this award. He chairs the scientific audit committee of the European Organisation for Research and Treatment of Cancer (EORTC) and is a member of the EORTC Board.
Dr. Tannock was appointed a Member of the Order of Canada in December 2013.
研究兴趣
论文共 614 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neoplasia: An International Journal for Oncology Research (2024): 100994
引用0浏览0引用
0
0
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2024)
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 8 (2024): 974-975
Cancer chemotherapy and pharmacologypp.1-2, (2024)
Neoplasia (2024): 100994
Neoplasia (New York, N.Y.) (2024): 100994-100994
Q. Tan, A. M. Joshua, J. K. Saggar, M. Yu, M. Wang, N. Kanga, J. Y. Zhang,X. Chen, B. G. Wouters,I. F. Tannock
British Journal of Cancerpp.1-1, (2024)
The Lancet. Oncologyno. 6 (2023): 589-593
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn